The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intrauterine Contraceptive Market Research Report 2025
Synopsis
An intrauterine contraceptive device is a medical device, which is inserted in the uterus to prevent conception. A plastic string is attached to the end of the device to ensure correct placement and its removal. These devices are available in various forms, such as coil, loop, triangle, and T-shaped, and are made up of plastic or metal. An intrauterine contraceptive device may also be used as an emergency contraception method after unprotected sex. An intrauterine contraceptive device is inserted into the uterus with the help of health care professionals.
The global Intrauterine Contraceptive market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intrauterine Contraceptive, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intrauterine Contraceptive.
Report Scope
The Intrauterine Contraceptive market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intrauterine Contraceptive market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intrauterine Contraceptive manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
DKT International
Melbea AG
Pregna International Limited
Ocon Medical Ltd
SMB Corporation of India
Mona Lisa N.V.
Segment by Type
Nonhormonal Intrauterine Contraceptive Devices
Hormonal Intrauterine Contraceptive Devices
Segment by Application
Hospitals
Community Health Care Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intrauterine Contraceptive manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intrauterine Contraceptive in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An intrauterine contraceptive device is a medical device, which is inserted in the uterus to prevent conception. A plastic string is attached to the end of the device to ensure correct placement and its removal. These devices are available in various forms, such as coil, loop, triangle, and T-shaped, and are made up of plastic or metal. An intrauterine contraceptive device may also be used as an emergency contraception method after unprotected sex. An intrauterine contraceptive device is inserted into the uterus with the help of health care professionals.
The global Intrauterine Contraceptive market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intrauterine Contraceptive, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intrauterine Contraceptive.
Report Scope
The Intrauterine Contraceptive market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intrauterine Contraceptive market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intrauterine Contraceptive manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
DKT International
Melbea AG
Pregna International Limited
Ocon Medical Ltd
SMB Corporation of India
Mona Lisa N.V.
Segment by Type
Nonhormonal Intrauterine Contraceptive Devices
Hormonal Intrauterine Contraceptive Devices
Segment by Application
Hospitals
Community Health Care Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intrauterine Contraceptive manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intrauterine Contraceptive in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Intrauterine Contraceptive Market Overview
1.1 Product Overview and Scope of Intrauterine Contraceptive
1.2 Intrauterine Contraceptive Segment by Type
1.2.1 Global Intrauterine Contraceptive Market Value Comparison by Type (2024-2030)
1.2.2 Nonhormonal Intrauterine Contraceptive Devices
1.2.3 Hormonal Intrauterine Contraceptive Devices
1.3 Intrauterine Contraceptive Segment by Application
1.3.1 Global Intrauterine Contraceptive Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Community Health Care Centers
1.3.4 Others
1.4 Global Intrauterine Contraceptive Market Size Estimates and Forecasts
1.4.1 Global Intrauterine Contraceptive Revenue 2019-2030
1.4.2 Global Intrauterine Contraceptive Sales 2019-2030
1.4.3 Global Intrauterine Contraceptive Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intrauterine Contraceptive Market Competition by Manufacturers
2.1 Global Intrauterine Contraceptive Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intrauterine Contraceptive Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intrauterine Contraceptive Average Price by Manufacturers (2019-2024)
2.4 Global Intrauterine Contraceptive Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intrauterine Contraceptive, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intrauterine Contraceptive, Product Type & Application
2.7 Intrauterine Contraceptive Market Competitive Situation and Trends
2.7.1 Intrauterine Contraceptive Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intrauterine Contraceptive Players Market Share by Revenue
2.7.3 Global Intrauterine Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intrauterine Contraceptive Retrospective Market Scenario by Region
3.1 Global Intrauterine Contraceptive Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intrauterine Contraceptive Global Intrauterine Contraceptive Sales by Region: 2019-2030
3.2.1 Global Intrauterine Contraceptive Sales by Region: 2019-2024
3.2.2 Global Intrauterine Contraceptive Sales by Region: 2025-2030
3.3 Global Intrauterine Contraceptive Global Intrauterine Contraceptive Revenue by Region: 2019-2030
3.3.1 Global Intrauterine Contraceptive Revenue by Region: 2019-2024
3.3.2 Global Intrauterine Contraceptive Revenue by Region: 2025-2030
3.4 North America Intrauterine Contraceptive Market Facts & Figures by Country
3.4.1 North America Intrauterine Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intrauterine Contraceptive Sales by Country (2019-2030)
3.4.3 North America Intrauterine Contraceptive Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intrauterine Contraceptive Market Facts & Figures by Country
3.5.1 Europe Intrauterine Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intrauterine Contraceptive Sales by Country (2019-2030)
3.5.3 Europe Intrauterine Contraceptive Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intrauterine Contraceptive Market Facts & Figures by Country
3.6.1 Asia Pacific Intrauterine Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intrauterine Contraceptive Sales by Country (2019-2030)
3.6.3 Asia Pacific Intrauterine Contraceptive Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intrauterine Contraceptive Market Facts & Figures by Country
3.7.1 Latin America Intrauterine Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intrauterine Contraceptive Sales by Country (2019-2030)
3.7.3 Latin America Intrauterine Contraceptive Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intrauterine Contraceptive Market Facts & Figures by Country
3.8.1 Middle East and Africa Intrauterine Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intrauterine Contraceptive Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intrauterine Contraceptive Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intrauterine Contraceptive Sales by Type (2019-2030)
4.1.1 Global Intrauterine Contraceptive Sales by Type (2019-2024)
4.1.2 Global Intrauterine Contraceptive Sales by Type (2025-2030)
4.1.3 Global Intrauterine Contraceptive Sales Market Share by Type (2019-2030)
4.2 Global Intrauterine Contraceptive Revenue by Type (2019-2030)
4.2.1 Global Intrauterine Contraceptive Revenue by Type (2019-2024)
4.2.2 Global Intrauterine Contraceptive Revenue by Type (2025-2030)
4.2.3 Global Intrauterine Contraceptive Revenue Market Share by Type (2019-2030)
4.3 Global Intrauterine Contraceptive Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intrauterine Contraceptive Sales by Application (2019-2030)
5.1.1 Global Intrauterine Contraceptive Sales by Application (2019-2024)
5.1.2 Global Intrauterine Contraceptive Sales by Application (2025-2030)
5.1.3 Global Intrauterine Contraceptive Sales Market Share by Application (2019-2030)
5.2 Global Intrauterine Contraceptive Revenue by Application (2019-2030)
5.2.1 Global Intrauterine Contraceptive Revenue by Application (2019-2024)
5.2.2 Global Intrauterine Contraceptive Revenue by Application (2025-2030)
5.2.3 Global Intrauterine Contraceptive Revenue Market Share by Application (2019-2030)
5.3 Global Intrauterine Contraceptive Price by Application (2019-2030)
6 Key Companies Profiled
6.1 DKT International
6.1.1 DKT International Corporation Information
6.1.2 DKT International Description and Business Overview
6.1.3 DKT International Intrauterine Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.1.4 DKT International Intrauterine Contraceptive Product Portfolio
6.1.5 DKT International Recent Developments/Updates
6.2 Melbea AG
6.2.1 Melbea AG Corporation Information
6.2.2 Melbea AG Description and Business Overview
6.2.3 Melbea AG Intrauterine Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Melbea AG Intrauterine Contraceptive Product Portfolio
6.2.5 Melbea AG Recent Developments/Updates
6.3 Pregna International Limited
6.3.1 Pregna International Limited Corporation Information
6.3.2 Pregna International Limited Description and Business Overview
6.3.3 Pregna International Limited Intrauterine Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pregna International Limited Intrauterine Contraceptive Product Portfolio
6.3.5 Pregna International Limited Recent Developments/Updates
6.4 Ocon Medical Ltd
6.4.1 Ocon Medical Ltd Corporation Information
6.4.2 Ocon Medical Ltd Description and Business Overview
6.4.3 Ocon Medical Ltd Intrauterine Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ocon Medical Ltd Intrauterine Contraceptive Product Portfolio
6.4.5 Ocon Medical Ltd Recent Developments/Updates
6.5 SMB Corporation of India
6.5.1 SMB Corporation of India Corporation Information
6.5.2 SMB Corporation of India Description and Business Overview
6.5.3 SMB Corporation of India Intrauterine Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SMB Corporation of India Intrauterine Contraceptive Product Portfolio
6.5.5 SMB Corporation of India Recent Developments/Updates
6.6 Mona Lisa N.V.
6.6.1 Mona Lisa N.V. Corporation Information
6.6.2 Mona Lisa N.V. Description and Business Overview
6.6.3 Mona Lisa N.V. Intrauterine Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mona Lisa N.V. Intrauterine Contraceptive Product Portfolio
6.6.5 Mona Lisa N.V. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intrauterine Contraceptive Industry Chain Analysis
7.2 Intrauterine Contraceptive Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intrauterine Contraceptive Production Mode & Process
7.4 Intrauterine Contraceptive Sales and Marketing
7.4.1 Intrauterine Contraceptive Sales Channels
7.4.2 Intrauterine Contraceptive Distributors
7.5 Intrauterine Contraceptive Customers
8 Intrauterine Contraceptive Market Dynamics
8.1 Intrauterine Contraceptive Industry Trends
8.2 Intrauterine Contraceptive Market Drivers
8.3 Intrauterine Contraceptive Market Challenges
8.4 Intrauterine Contraceptive Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
